ARTICLE | Clinical News
Fluoratec: Began Phase I/II testing
May 22, 2000 7:00 AM UTC
Boston Life Sciences Inc. (BLSI), Boston, Mass. Product: Fluoratec Business: Diagnostics/Imaging, Neurological Therapeutic category: Test Target: Dopamine transporters in the brain Description: Techne...